Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Income from Continuing Operations (2016 - 2025)

Xtant Medical Holdings has reported Income from Continuing Operations over the past 16 years, most recently at 57000.0 for Q4 2025.

  • Quarterly Income from Continuing Operations rose 101.8% to 57000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4973000.0 through Dec 2025, up 130.23% year-over-year, with the annual reading at 4973000.0 for FY2025, 130.23% up from the prior year.
  • Income from Continuing Operations was 57000.0 for Q4 2025 at Xtant Medical Holdings, down from 1308000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 9231000.0 in Q3 2023 and troughed at 6204000.0 in Q4 2023.
  • The 5-year median for Income from Continuing Operations is 2134000.0 (2023), against an average of 1307300.0.
  • Year-over-year, Income from Continuing Operations crashed 7531.03% in 2022 and then soared 492.31% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 2377000.0 in 2021, then increased by 7.07% to 2209000.0 in 2022, then crashed by 180.85% to 6204000.0 in 2023, then surged by 48.98% to 3165000.0 in 2024, then skyrocketed by 101.8% to 57000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Income from Continuing Operations are 57000.0 (Q4 2025), 1308000.0 (Q3 2025), and 3550000.0 (Q2 2025).